Author:
Boccuzzi S. J.,Keegan M. E.,Hirsch L. J.,Shapiro D. R.,Plotkin D. J.,Mitchel Y. B.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),General Medicine,Pharmacology (medical)
Reference20 articles.
1. Arad Y, Ramakrishnan R, Ginsberg HN. Lovastatin therapy reduces low density lipoprotein apoB levels in subjects with combined hyperlipidemia by reducing the production of apoB-containing lipoproteins: implications for the pathophysiology of apoB production. Journal of Lipid Research 30: 567–582, 1990
2. Barth JD, Kruisbrink OA, Van Eijk AL. Sleep duration and sleep patterns during simvastatin therapy (Abstract). Tenth International Symposium on Drugs Affecting Lipid Metabolism, Houston, Texas, No. 514, 1989
3. Boccuzzi SJ, Bocanegra TS, Walker JF, Shapiro DR, Keegan ME. Long term safety and efficacy profile of simvastatin. American Journal of Cardiology 68: 1127–1131, 1991
4. Bradford RH, Shear CI, Chremos AN, DuJovne C, Downtown M, et al. Expanded clinical evaluation of lovastatin (EXCEL) study results. Archives of Internal Medicine 151: 43–49, 1991
5. Eckernas SA, Roos BE, Kvidal P, Eriksson L-O, Block GA, et al. The effects of simvastatin and pravastatin on objective and subjective measures of nocturnal sleep: a comparison of two structurally different HMG CoA reductase inhibitors in patients with primary moderate hypercholesterolemia. British Journal of Clinical Pharmacology, in press, 1993
Cited by
24 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献